Company news
Bio-Thera Solutions, Ltd. news in 2023
Bio-Thera Solutions, Ltd.'s news releases, calls and decks from 2023, newest first.
Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, a Stelara® Biosimilar
June 16, 2023
Bio-Thera Solutions Announces BAT1006 Poster Presentations at the 2023 AACR Annual Meeting
April 17, 2023
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8007, an Antibody-Drug Conjugate Targeting Nectin-4 for the Treatment of Advanced Solid Tumors
March 13, 2023
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
March 8, 2023
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug Conjugate Targeting HER2 for the Treatment of Advanced Solid Tumors
March 6, 2023
China NMPA Approves Bio-Thera Solutions' BAT1806, A Biosimilar to Actemra
January 17, 2023